文献速递糖尿病肥胖与代谢综合征

糖尿病病程、血糖控制与成人糖尿病患者心力衰竭风险:一项队列研究

Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究纳入英国生物银行基线招募时无心力衰竭的23754例糖尿病患者,采用多因素Cox模型分析自我报告的糖尿病病程及糖化血红蛋白(HbA1c)水平与新发心力衰竭的关联。结果显示,糖尿病病程和HbA1c水平均与心力衰竭风险呈正相关,且病程≥15年合并HbA1c≥63.9 mmol/mol(8.0%)者风险尤其增高(交互作用P=0.026)。

要点

  • 糖尿病病程≥15年者心力衰竭风险较病程<5年者升高,HR为1.32(95%CI 1.15-1.53)。
  • HbA1c≥63.9 mmol/mol(8.0%)者心力衰竭风险较HbA1c<53.0 mmol/mol(7.0%)者升高,HR为1.46(95%CI 1.30-1.65)。
  • 病程≥15年且HbA1c≥8.0%者心力衰竭风险尤其增高,交互作用P=0.026。

核心结论

  • 糖尿病患者心力衰竭风险随糖尿病病程延长和HbA1c水平升高而增加。
  • 该发现若在临床实践和政策制定中加以考虑,可能有助于糖尿病患者心力衰竭的个体化预防。

研究设计与样本

  • 研究纳入英国生物银行基线招募时无心力衰竭的23754例糖尿病患者。
  • 糖尿病病程为自我报告,血糖控制状态以糖化血红蛋白A1c(HbA1c)水平反映。
  • 采用多因素Cox模型评估糖尿病病程及HbA1c与新发心力衰竭的关联,并校正传统危险因素。

主要发现

  • 与糖尿病病程<5年者相比,病程5至<10年、10至<15年、≥15年者心力衰竭的HR(95%CI)分别为1.09(0.97-1.23)、1.13(0.97-1.30)、1.32(1.15-1.53)。
  • 与HbA1c<53.0 mmol/mol(7.0%)者相比,HbA1c 53.0至<58.5 mmol/mol(7.0%至<7.5%)、58.5至<63.9 mmol/mol(7.5%至<8.0%)、≥63.9 mmol/mol(8.0%)者心力衰竭的HR(95%CI)分别为1.15(1.02-1.31)、1.07(0.91-1.26)、1.46(1.30-1.65)。
  • 糖尿病病程≥15年且HbA1c≥63.9 mmol/mol(8.0%)的个体心力衰竭风险尤其增高(交互作用P=0.026)。

临床怎么用

  • 原文结论指出,若在临床实践和政策制定中考虑该发现,可能有助于糖尿病患者心力衰竭的个体化预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The influences of diabetes duration and glycemic control and their potential interplays on the risk of heart failure (HF) remain unclear. OBJECTIVE: This work aimed to investigate the association of diabetes duration and glycemic control with the risk of HF. METHODS: A total of 23 754 individuals with diabetes but without HF during the baseline recruitment of UK Biobank were included in this study. Duration of diabetes was self-reported, and the status of glycemic control was reflected by glycated hemoglobin A1c (HbA1c) levels. Their associations with incident HF were assessed using multivariate Cox models adjusting for traditional risk factors. RESULTS: Duration of diabetes and HbA1c levels both were positively associated with the risk of HF. The hazard ratios (HRs) (95% CI) for diabetes durations of 5 to less than 10, 10 to less than 15, and 15 years or more were 1.09 (0.97-1.23), 1.13 (0.97-1.30), and 1.32 (1.15-1.53), respectively (vs < 5 years); and the HRs for HbA1c of 53.0 to less than 58.5 mmol/mol (7.0% to < 7.5%), 58.5 to less than 63.9 mmol/mol (7.5% to < 8.0%), and 63.9 mmol/mol or greater (8.0%) were 1.15 (1.02-1.31), 1.07 (0.91-1.26), and 1.46 (1.30-1.65), respectively (vs < 53.0 mmol/mol [7.0%]). Individuals with the longest disease duration (≥ 15 years) and poorer glycemic control (HbA1c ≥ 63.9 mmol/mol [8.0%]) had a particularly higher risk of HF (P for interaction = .026). CONCLUSION: The risk of HF among individuals with diabetes increases with a longer duration of diabetes and increasing HbA1c levels. This finding may contribute to the individualized prevention of HF in patients with diabetes if being considered in clinical practices and policy-making.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yang HH, Li FR, Chen ZK, et al. Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study. J Clin Endocrinol Metab. 2023. PMID: 36383477. doi:10.1210/clinem/dgac642

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。